Abstracts.TLD8_11.Cov1_4 10/4/04 10:27 AM Page 1 (2,1) VOLUME 8 PAGES S1–S244 VOLUME 8 NUMBER 1 NUMBER 11 ISSN 1027 3719 NOVEMBER 2004 The SUPPLEMENT 1 1 International NOVEMBER 2004 SUPPLEMENT Journal of Tuberculosis and Lung Disease 1 The Official Journal of the International Union Against Tuberculosis and Lung Disease THE INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ABSTRACT BOOK 35th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease PARIS • FRANCE 28 OCTOBER–1 NOVEMBER 2004 PAGES S1–S244 PAGES Awards of the International Union Against Tuberculosis and Lung Disease At each Annual Union World Conference the following awards are presented: Two prizes of US $2000.00: –A Scientific Prize is awarded to a young researcher (under 45 years of age) for his/her work on tuberculosis or non-tuberculous lung disease published in the last 2 years. One copy of the publication should be sent to the Union Secretariat with the candidate’s application. –A Public Health Prize (The Karel Styblo Prize) is awarded to a health worker (physician or lay person) for his/her contribution to tuberculosis control or non-tuberculous lung disease. Applicants should include a well-documented description of his/her work, together with the comments of the manager of the association or programme. Applications, including a full curriculum vitae, should be sent by the candidates to the Union Secretariat in Paris 3 months before the World Conference (i.e., 1 July 2005). The title of Honorary Member of the Union is granted to a person who has distinguished him/herself in active participation in the Union’s activities and fulfilment of its goals. UNION Constituent Members can nominate likely candidates 3 months before the World Conference (i.e., 1 July 2005). The Union Medal is awarded to those members who have made an outstanding contribution to the control of tuberculosis or non-tuberculous lung disease, by their scientific work and/or actions in the field. Union Regional Conferences 2005 9TH Conference of the Union 25TH Conference of the Union North American Region Middle East Region 22–26 FEBRUARY 2005 5–7 APRIL 2005 VANCOUVER, BC, CANADA DAMASCUS, SYRIA For more information, please contact: For more information, please contact: Menn Biagtan, MD, MPH Dr Abdul Ghani Arafeh Conference Secretariat, Union-NAR President, Syrian Committee Against TB and British Columbia Lung Association Respiratory Diseases 2675 Oak Street Al Mahdi Bin Baraka St. Vancouver, BC V6H 2K2, CANADA P O Box 144 Tel: (+1) 604-731-5864 Damascus, SYRIA Fax: (+1) 604-731-5810 Tel: (+963) 33 33 760 e-mail: [email protected] or Fax: (+963) 33 34 685 [email protected] e-mail: [email protected] 11TH Conference of the Union 23RD Conference of the Union Latin America Region Eastern Region 23 MARCH–1 APRIL 2005 25–29 SEPTEMBER 2005 MERIDA, MEXICO LAHORE, PAKISTAN For more information, please contact: For more information, please contact: Sociedad Mexicana de Neumología CH Muhammad Nawaz y Cirugía de Tórax President, Union Eastern Region, and Instituto Nacional de Enfermedades Pakistan Anti-TB Association Respiratorias Health Complex Calzada de Tlalpan 4502 16-K Gulberg III Col. V Sección XVI CP 14080 Lahore, PAKISTAN México DF MEXICO Tel: (+92) 42 575 6986 Tel: (+55) 5211 2350 Fax: (+92) 42 575 5086 Fax: (+55) 5211 2353 e-mail: [email protected] e-mail: [email protected] www.smnyct.org.mx The International Journal of Tuberculosis and Lung Disease SUPPLEMENT VOLUME 8 NUMBER 11 NOVEMBER 2004 SECTION 1: Poster discussion sessions (PC) S1 PLENARY SESSIONS S44 DOTS expansion S48 Clinical trials and tuberculosis basic science S51 Policy and programme implementation: TB and HIV SECTION 2: SYMPOSIA S55 Clinical research and smear examination SATURDAY, 30 OCTOBER 2004 S2 HIV/TB lung disease: turning the tide to reach the child Poster display sessions (PS) MDGs by 2015 S58 Clinical trials and drug development S3 Tuberculosis in prisons or closed institutions S65 Drug resistance/MDR-TB management–1 S5 Impact of new mechanisms to increase access to high S70 Tuberculosis and HIV quality anti-tuberculosis drugs S76 Tuberculosis in high-burden countries–1 S6 Drug resistance: is it worth measuring? S83 Epidemiology of TB: special populations and institutions S7 Emergency and continuing care in asthma (migrants, hospitals, prisons)–1 S9 CREATE, a response to TB/HIV S88 Tuberculosis and poverty S11 Ensuring quality of care in DOTS implementation/ S95 DOTS: public-private mix integrating laboratory, NTPs and organisation S100 Tobacco and air pollution–1 S13 Tuberculosis prevalence surveys S14 Drug resistance and treatment of MDR-TB S15 Loopholes in national legislations: need for SUNDAY, 31 OCTOBER 2004 international regulations—the FCTC Thematic slide presentations (TS) S16 Can you get tuberculosis from your food? S105 Progress in TB control Poster discussion sessions (PC) SUNDAY, 31 OCTOBER 2004 S107 Epidemiology of tuberculosis and tobacco S17 HIV/TB: scaling up the use of ARVs—links to TB control S111 Drug resistance/MDR-TB management S18 Advances in the development of new diagnostic tests S115 Training, human resources and community participation for tuberculosis S118 Diagnostic methods and drug susceptibility S20 Improvement of indoor and ambient air quality in Poster display sessions (PS) developing countries S121 Bacteriology and immunology S20 Women, tobacco, lung health and the economic S129 Clinical tuberculosis consequences S134 Drug resistance/MDR-TB management–2 S20 Enhancing case finding: report on FIDELIS projects S140 Tuberculosis and lung disease in children in China S146 Practical Approach to Lung Health (PAL) and asthma S22 Tuberculosis management in children: obstacles to S154 Tuberculosis in high-burden countries–2 reaching the millennium developement goals S161 Patient treatment adherence/management–1 S23 Incentives for DOTS performance: enabling or S166 Policy and programme implementation: TB control in corrupting? special populations and institutions S24 TB in mobile populations and in persons with undocumented residence status S26 Operational research to improve National Tuberculosis MONDAY, 1 NOVEMBER 2004 Programmes Thematic slide presentations (TS) S28 Bacterial virulence of tubercle bacilli and genetic S173 Education, advocacy and social issues susceptibility in humans S29 New TB drug development Poster discussion sessions (PC) S176 Epidemiology of tuberculosis S179 Clinical research and treatment of lung disease MONDAY, 1 NOVEMBER 2004 S182 Tuberculosis and society/poverty S30 TB treatment adherence in resource-poor settings S184 Management innovations to improve the quality S31 Human resource development for TB control of DOTS S33 Harm reduction and funding by tobacco transnationals S34 Microscopy and culture Poster display sessions (PS) S37 Contact investigation and active case finding in high S187 Tuberculosis diagnosis incidence countries S194 Tuberculosis in low-burden countries S37 HIV/TB: two diseases, one patient S200 Epidemiology of TB: special populations and institutions S39 Scaling up public-private mix for DOTS: how can it (migrants, hospitals, prisons)–2 contribute to achieving MDGs? S205 DOTS expansion S212 Tuberculosis education and training S219 Drug resistance/MDR-TB management–3 SECTION 3: POSTER SESSIONS S224 Patient treatment adherence/management–2 SATURDAY, 30 OCTOBER 2004 S230 Tobacco and air pollution–2 Thematic slide presentations (TS) S42 Clinical trials and tuberculosis basic science S235 INDEX The International Journal of Tuberculosis and Lung Disease Editors-in-Chief Tuberculosis Nulda Beyers, University of Stellenbosch, Tygerberg, South Africa Lung Disease Moira Chan-Yeung, University of Hong Kong, Hong Kong SAR, China Associate Editors NADIA AI¨ T-KHALED (Algeria) MARCOS ESPINAL (Dominican Republic) ALWYN MWINGA (Zambia) ISABELLA ANNESI-MAESANO (France) ANNE FANNING (Canada) MELANIE NEWPORT (UK) PER S BAKKE (Norway) VICTORINO FARGA (Chile) IDA ONORATO (USA) ERIC BATEMAN (South Africa) PAUL E M FINE (UK) ARIEL PABLOS-MENDEZ (Mexico) MARGARET BECKLAKE (Canada) MARK FITZGERALD (Canada) RAMESH PANCHAGNULA (India) MARTIEN BORGDORFF (The Netherlands) STEPHEN GILLESPIE (UK) CHRISTIAN PERRONNE (France) MAARTEN BOSMAN (The Netherlands) TONY HARRIES (Malawi) FRANÇOISE PORTAELS (Belgium) HARRY CAMPBELL (UK) LEONID HEIFETS (USA) MARY REICHLER (USA) MANUEL CASAL (Spain) CHRISTER JANSON (Sweden) RENÉE RIDZON (USA) KEN CASTRO (USA) STEFAN KAUFMANN (Germany) HANS L RIEDER (Switzerland) RICHARD E CHAISSON (USA) JULIA KEMP (Malawi) TOM SHINNICK (USA) PIERRE CHAULET (Algeria) SANG JAE KIM (Korea) KAREN SLAMA (France) PATRICK CHAULK (USA) AFRANIO KRITSKI (Brazil) OUMOU Y SOW (Guinea) BOB COWIE (Canada) ROBERT LODDENKEMPER (Germany) JEFFREY R STARKE (USA) PETER D O DAVIES (UK) GUY MARKS (Australia) JEAN-FRANÇOIS TESSIER (France) KEVIN M DE COCK (USA) BESS MILLER (USA) CHARLES THOEN (USA) HAZEL DOCKRELL (UK) LIZ MOLYNEUX (Malawi) MUKUND UPLEKAR (India) DONALD A ENARSON (Canada) JOHN F MURRAY (USA) GIOVANNI VIEGI (Italy) Ex-officio members (Union) President of the Union, Union Director of Scientific Activities, Michael Iseman (Emeritus, USA) Manuscripts and correspondence MANAGING EDITOR CLARE PIERARD DIRECTOR OF PUBLICATIONS NILS E BILLO TECHNICAL EDITOR LISA SALYER MEMBERSHIP/SUBSCRIPTIONS [email protected] EDITORIAL ASSISTANT JULIE BENNETOT EDITORIAL OFFICE Union, 68 boulevard Saint Michel, 75006 Paris, FRANCE Tel: (+33 1) 44 32 03 60 Fax: (+33 1) 43 29 90 83 e-mail: [email protected] website: www.iuatld.org aims